4″ Meey” 2021″ SOURCE: NEWS AGENCIES
Tallaabada ugu horreysa ee oggolaanshaha suurtagalka ah waxay imaaneysaa ka dib markii daraasado la soo jeediyay ay tallaalka soo saaraan jawaab celin ka dhan ah coronavirus
Tallaalka Sinovac wuxuu kakooban yahay noocyada firidhsan ama dhintay ee fayraska SARS-CoV-2 si looga caawiyo habka difaaca jirka ee jirka inuu sameeyo unugyada difaaca jirka wuxuuna muujiyey heerka waxtarka udhaxeeya 50 boqolkiiba iyo 90 boqolkiiba daraasado kaladuwan sida ay ku warantay wakaalada wararka Reuters
Xayeeysiin
Maamulaha dawooyinka Midowga Yurub ayaa bilaabay dib u eegis isdabajoog ah oo ku saabsan tallaalka COVID-19 ee ay soo saartay shirkadda dawooyinka ee Sinovac ee Shiinaha si loo qiimeeyo waxtarkeeda iyo nabadgelyadiisa, taas oo calaamadeynaysa tallaabada ugu horreysa ee ku aaddan ansixinteeda suurtagalka ah ee loogu talagalay isticmaalka 27-ka dal.
Wakaaladda dawooyinka Yurub (EMA) ayaa khamiistii sheegtay in go’aanka ay ku bilaabayso dib-u-eegista ay ku salaysnayd natiijooyinka hordhaca ah ee shaybaadhka iyo daraasadaha caafimaadka, ee ku lug leh xayawaanka iyo dadka, taas oo soo jeedinaysa in tallaalku soo saarayo jawaab ka dhan ah coronavirus.
Xaaladaha COVID ee Hindiya ayaa kor u kacaya sida ogsijiinta, yaraanta tallaalka ayaa sii socotaVenezuela si ay u bilawdo tijaabooyinka bukaan socodka ee murashaxa tallaalka Cuba Nidaamka ugu weyn ee Hindiya ee tallaalka Serum wuxuu daboolay kaliya 4% dadka
“Daraasadahaani waxay soo jeedinayaan in tallaalku uu kicinayo soo saarista unugyada difaaca jirka… ayna gacan ka geysan karto kahortagga cudurka,” ayay hay’addu ku tiri hadal ay soo saartay.
Tallaalka Sinovac wuxuu ka kooban yahay noocyo firidhsan ama dhintay oo ah fayraska SARS-CoV-2 si looga caawiyo habka difaaca jirka aadanaha inuu sameeyo unugyada difaaca jirka, taas oo muujisay heerarka waxtarka u dhexeeya 50 boqolkiiba iyo 90 boqolkiiba daraasado kala duwan.
Tallaalka waxaa hadda loo oggol yahay in lagu isticmaalo Shiinaha, Indonesia, Brazil iyo Turkiga” Bshii Abriil, Sinovac waxay sheegtay in Warshaddeedii saddexaad ee wax soo saar ee tallaalkeeda, ay ku calaamadeyso gobollada qaarkood CoronaVac, ay diyaar tahay, iyadoo labanlaabaysa awooddeeda sannadlaha ah oo gaareysa laba bilyan oo qiyaaso ah.
Dib u eegista wareejinta
Sinovac waa tallaalkii ugu horreeyay ee Shiinaha ee EMA ay barato waqtiga dhabta ah.
Hay’addu waxay sidoo kale wadaa dib-u-eegis isdaba-joog ah oo ku saabsan seddex tallaal oo kale: mid ay soo saartay shirkadda Jarmalka biotech ee CureVac, mid kalena ay soo saartay shirkadda Mareykanka ee Novavax, iyo mid saddexaad – Sputnik V. ee Ruushka ah.
Dib-u-eegista wareejinta waxaa loogu talagalay in lagu dedejiyo hannaanka oggolaanshaha iyadoo loo oggolaanayo cilmi-baarayaasha inay soo gudbiyaan natiijooyinka waqtiga dhabta ah ka hor inta aan la helin xogta tijaabada ugu dambeysa.
Hay’addu waxay sheegtay in khubaradeeda ay qiimeyn doonaan xogta “si loo go’aamiyo haddii faa’iidooyinka ay ka culus yihiin halista” toogashada Sinovac.
Majiro xog daraasad wajiga 3 ah oo ku saabsan talaalka wali laguma soo saarin joornaalada dib loo eegay.
Cilmi-baarista sida aadka ah isha loogu hayey waxay ku lug lahayd ilaa 12,000 oo shaqaale caafimaad ah oo ku sugan Brazil, halkaas oo cilmi-baarayaashu ay ka warbixiyeen boqolkiiba 50.7 waxtarka ka dhanka ah astaamaha COVID-19 iyo difaac aad u xoog badan oo ka dhan ah cudurrada daran.
Dib-u-eegista dib-u-eegista ee EMA ayaa sii socon doonta illaa “caddayn ku filan loo heli karo dalab rasmi ah oo oggolaansho suuq-geyn ah”, ayay hay’addu sheegtay, iyadoo intaa ku dartay inaysan saadaalin karin waqtiyada iyo in aan weli la soo gudbin codsi raadinaya oggolaansho noocaas ah ee tallaalka Sinovac.
Warkan ka soo baxay hay’adda fadhigeedu yahay Amsterdam ayaa yimid maalin uun ka dib markii sarkaal sare oo ka tirsan Hay’adda Caafimaadka Adduunka (WHO) uu sheegay in hay’adda Qaramada Midoobay ay qarka u saaran tahay inay go’aan ka gaarto toddobaadkan in la ansixiyo laba tallaal oo Shiinaha laga leeyahay oo loo yaqaan ‘COVID-19’ oo loogu talagalay isticmaalka degdegga ah.
Ansixinta noocan oo kale ah waxay calaamad u tahay markii ugu horeysay ee tallaalka Shiinaha la siiyo waxa loogu yeero liistada isticmaalka degdegga ah ee hay’adda caafimaadka ee Qaramada Midoobay, waxayna kicin doontaa soo saar ballaaran oo tallaallada Shiinaha ah oo horeyba loogu isticmaalay dalal ka baxsan Shiinaha.
SOURCE: NEWS AGENCIES